On January 10, 2025, Felipe Duran, Chief Financial Officer of iBio Inc, acquired 9,191 shares of iBio Inc (IBIO, Financial). Following this transaction, the insider now holds a total of 11,139 shares in the company. The purchase was documented in a SEC Filing. iBio Inc is a biotechnology company that focuses on developing plant-based biologics. The company leverages its proprietary technology to produce vaccines, therapeutics, and other biopharmaceutical products. The insider's recent purchase aligns with a broader trend of insider buying within the company. Over the past year, there have been seven insider buys and no insider sells, indicating a positive sentiment among the company's insiders.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
